Status: current, Defined. Date: 31-Dec 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4497191000168116 | Femoston-Conti (dydrogesterone 5 mg + estradiol 1 mg) tablet, 7 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4497201000168118 | Femoston-Conti tablet, 7 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4497271000168111 | Femoston-Conti (dydrogesterone 5 mg + oestradiol 1 mg) tablet, 7 tablets | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Femoston-Conti tablet, 7 | Is a | estradiol 1 mg + dydrogesterone 5 mg tablet, 7 | true | Inferred relationship | Some | ||
| Femoston-Conti tablet, 7 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Femoston-Conti tablet, 7 | has TP | Femoston-Conti | true | Inferred relationship | Some | ||
| Femoston-Conti tablet, 7 | has TPUU | Femoston-Conti tablet | true | Inferred relationship | Some | 1761524540 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Femoston-Conti tablet, 7, blister pack | Is a | True | Femoston-Conti tablet, 7 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR